BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 15271374)

  • 1. Human interleukin-5 expression is synergistically regulated by histone acetyltransferase CBP/p300 and transcription factors C/EBP, NF-AT and AP-1.
    Liu C; Lu J; Tan J; Li L; Huang B
    Cytokine; 2004 Aug 21-Sep 7; 27(4-5):93-100. PubMed ID: 15271374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone acetyltransferase activity of p300 enhances the activation of IL-18 promoter.
    Sun H; Lu J; Xu X; Jin S; Wang X; Wei L; Dong M; Huang B
    J Cell Biochem; 2005 Feb; 94(3):566-72. PubMed ID: 15543578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone acetyltransferase p300 promotes the activation of human WT1 promoter and intronic enhancer.
    Shao Y; Lu J; Zhang G; Liu C; Huang B
    Arch Biochem Biophys; 2005 Apr; 436(1):62-8. PubMed ID: 15752709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.
    Ghosh AK; Yuan W; Mori Y; Varga J
    Oncogene; 2000 Jul; 19(31):3546-55. PubMed ID: 10918613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone acetyltransferase activity of p300 enhances the activation of IL-12 p40 promoter.
    Sun H; Lu J; Wei L; Wang X; Xu X; Dong M; Huang B
    Mol Immunol; 2004 Nov; 41(12):1241-6. PubMed ID: 15482860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The steroid receptor co-activator-1 (SRC-1) potentiates TGF-beta/Smad signaling: role of p300/CBP.
    Dennler S; Pendaries V; Tacheau C; Costas MA; Mauviel A; Verrecchia F
    Oncogene; 2005 Mar; 24(11):1936-45. PubMed ID: 15688032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A.
    Duyndam MC; van Dam H; Smits PH; Verlaan M; van der Eb AJ; Zantema A
    Oncogene; 1999 Apr; 18(14):2311-21. PubMed ID: 10327051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant negative mutant of c-Jun inhibits NF-AT transcriptional activity and prevents IL-2 gene transcription.
    Petrak D; Memon SA; Birrer MJ; Ashwell JD; Zacharchuk CM
    J Immunol; 1994 Sep; 153(5):2046-51. PubMed ID: 8051409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A composite C/EBP binding site is essential for the activity of the promoter of the IL-3/IL-5/granulocyte-macrophage colony-stimulating factor receptor beta c gene.
    van Dijk TB; Baltus B; Raaijmakers JA; Lammers JW; Koenderman L; de Groot RP
    J Immunol; 1999 Sep; 163(5):2674-80. PubMed ID: 10453008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes.
    Bandyopadhyay D; Okan NA; Bales E; Nascimento L; Cole PA; Medrano EE
    Cancer Res; 2002 Nov; 62(21):6231-9. PubMed ID: 12414652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p300/CBP-associated factor (P/CAF) interacts with nuclear respiratory factor-1 to regulate the UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase-3 gene.
    Izumi H; Ohta R; Nagatani G; Ise T; Nakayama Y; Nomoto M; Kohno K
    Biochem J; 2003 Aug; 373(Pt 3):713-22. PubMed ID: 12720548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of IL-6 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines.
    Takeshita S; Gage JR; Kishimoto T; Vredevoe DL; Martínez-Maza O
    J Immunol; 1996 Apr; 156(7):2591-8. PubMed ID: 8786324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation of SRC-1 and p300 with NF-kappaB and CREB in angiotensin II-induced IL-6 expression in vascular smooth muscle cells.
    Sahar S; Reddy MA; Wong C; Meng L; Wang M; Natarajan R
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1528-34. PubMed ID: 17495236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensinogen gene expression is dependent on signal transducer and activator of transcription 3-mediated p300/cAMP response element binding protein-binding protein coactivator recruitment and histone acetyltransferase activity.
    Ray S; Sherman CT; Lu M; Brasier AR
    Mol Endocrinol; 2002 Apr; 16(4):824-36. PubMed ID: 11923478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal expression of NF-IL6 and C/EBP in hepatocytes: possible involvement of NF-IL6 in acute phase protein gene expression.
    Isshiki H; Akira S; Sugita T; Nishio Y; Hashimoto S; Pawlowski T; Suematsu S; Kishimoto T
    New Biol; 1991 Jan; 3(1):63-70. PubMed ID: 1710143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C/EBPbeta enhances IL-4 but impairs IL-2 and IFN-gamma induction in T cells.
    Berberich-Siebelt F; Klein-Hessling S; Hepping N; Santner-Nanan B; Lindemann D; Schimpl A; Berberich I; Serfling E
    Eur J Immunol; 2000 Sep; 30(9):2576-85. PubMed ID: 11009091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment of histone deacetylase 4 by transcription factors represses interleukin-5 transcription.
    Han S; Lu J; Zhang Y; Cheng C; Han L; Wang X; Li L; Liu C; Huang B
    Biochem J; 2006 Dec; 400(3):439-48. PubMed ID: 16922677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor-IL6 activates the human IL-4 promoter in T cells.
    Davydov IV; Krammer PH; Li-Weber M
    J Immunol; 1995 Dec; 155(11):5273-9. PubMed ID: 7594540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific activation of hTERT-derived promoters by tumor suppressive E1A-mutants involves recruitment of p300/CBP/HAT and suppression of HDAC-1 and defines a combined tumor targeting and suppression system.
    Kirch HC; Ruschen S; Brockmann D; Esche H; Horikawa I; Barrett JC; Opalka B; Hengge UR
    Oncogene; 2002 Nov; 21(52):7991-8000. PubMed ID: 12439749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.